跳至主要内容
临床试验/EUCTR2009-011599-31-AT
EUCTR2009-011599-31-AT进行中(未招募)1 期

The effect of high-dose remifentanil on the reversal of established capsaicin-induced hyperalgesia in human volunteers

Abteilung für Anaesthesie und Intensivmedizin, Medizinische Universität Wien0 个研究点开始时间: 2009年4月21日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Men or women, aged between 19 and 40 years
  • Body mass index between 15th and 85th percentile
  • Normal findings in the medical history and physical examination
  • Drug free for 1 week prior to the study day
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Any of the following will exclude a subject from the study:
  • Regular use of medication especially analgesics,
  • Abuse of alcoholic beverages, drug abuse
  • History of asthma
  • Participation in a clinical trial in the 2 weeks preceding the study
  • Symptoms of a clinically relevant illness in the 2 weeks before the first study day
  • Resting systolic blood pressure >135 mmHg or diastolic blood pressure >85 mmHg
  • Pregnancy or breast feeding

研究者

发起方
Abteilung für Anaesthesie und Intensivmedizin, Medizinische Universität Wien

相似试验

The effect of high-dose remifentanil on the reversal... | 临床试验